There had not been a lot excellent information in Marten’s quarterly profits record. (Image: Jim …
Read More »COPD market anticipated to expand to $30.8 bn in the 7MM by 2033
The persistent obstructive lung condition (COPD) market in the 7 significant markets (7MM: United States, France, Germany, Italy, Spain, UK, and Japan) is readied to expand from sales of $11.5 bn in 2023 to $30.8 bn in 2033. The current authorizations of Sanofi/Regeneron’s Dupixent for COPD (from the European Medicines Agency/EMA in July 2024 and the United States Food and …
Read More »